BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18082673)

  • 1. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
    Bongiovanni R; Newbould E; Jaskiw GE
    Brain Res; 2008 Jan; 1190():39-48. PubMed ID: 18082673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine administration does not affect desipramine-induced dopamine levels as measured in vivo in prefrontal cortex.
    Bongiovanni R; Kirkbride B; Walmire P; Jaskiw GE
    Brain Res; 2005 Aug; 1054(2):203-6. PubMed ID: 16083866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R; Young D; Newbould E; Jaskiw GE
    Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
    Pan WH; Yang SY; Lin SK
    Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine depletion lowers in vivo DOPA synthesis in ventral hippocampus.
    Bongiovanni R; Kyser AN; Jaskiw GE
    Eur J Pharmacol; 2012 Dec; 696(1-3):70-6. PubMed ID: 23022716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
    Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
    J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
    Berridge CW; Stalnaker TA
    Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine.
    Pascucci T; Ventura R; Latagliata EC; Cabib S; Puglisi-Allegra S
    Cereb Cortex; 2007 Dec; 17(12):2796-804. PubMed ID: 17322559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine availability modulates potassium-induced striatal catecholamine efflux in vivo.
    Jaskiw GE; Newbould E; Bongiovanni R
    Brain Res; 2008 May; 1209():74-84. PubMed ID: 18400209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Longu G; Pira L; Gessa GL
    Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels.
    Jaskiw GE; Kirkbride B; Bongiovanni R
    Psychopharmacology (Berl); 2006 May; 185(4):416-22. PubMed ID: 16541248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
    Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F
    Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in magnitude of psychostimulant-induced extracellular norepinephrine in the ventral tegmental area contributes to discrepant prefrontal dopamine outflow.
    Pan WH; Hsieh MC; Wu HH; Lin SK
    Addict Biol; 2007 Mar; 12(1):51-8. PubMed ID: 17407497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-butyrolactone-induced dopamine accumulation in prefrontal cortex is affected by tyrosine availability.
    Jaskiw GE; Newbould E; Bongiovanni R
    Eur J Pharmacol; 2008 Jul; 589(1-3):106-9. PubMed ID: 18606405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.
    Clinton SM; Sucharski IL; Finlay JM
    Psychopharmacology (Berl); 2006 Jan; 183(4):404-12. PubMed ID: 16307295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
    Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
    J Neurochem; 1995 Jul; 65(1):111-6. PubMed ID: 7790854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress.
    Novick AM; Forster GL; Hassell JE; Davies DR; Scholl JL; Renner KJ; Watt MJ
    Neuropharmacology; 2015 Oct; 97():194-200. PubMed ID: 26056032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.